Table of Content

1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 16

1.2 MARKET ATTRACTIVENESS ANALYSIS 17

1.3 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA 18

1.4 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT 19

1.5 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER 20


2 MARKET INTRODUCTION
2.1 DEFINITION 21

2.2 SCOPE OF THE STUDY 21

2.3 RESEARCH OBJECTIVE 21

2.4 MARKET STRUCTURE 21

2.5 ASSUMPTIONS & LIMITATIONS 22


3 RESEARCH METHODOLOGY
3.1 DATA MINING 23

3.2 SECONDARY RESEARCH 24

3.3 PRIMARY RESEARCH 25

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 26

3.5 FORECASTING TECHNIQUES 27

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 28

3.6.1 BOTTOM-UP APPROACH 29

3.6.2 TOP-DOWN APPROACH 29

3.7 DATA TRIANGULATION 30

3.8 VALIDATION 30


4 MARKET DYNAMICS
4.1 OVERVIEW 31

4.2 DRIVERS 32

4.2.1 RISING IMPORTANCE OF BODY AESTHETICS 32

4.2.2 SOCIAL AND CULTURAL FACTORS SUCH AS INFLUENCE OF FASHION AND FILM INDUSTRIES 32

4.3 RESTRAINTS 33

4.3.1 STRINGENT REGULATORY POLICIES 33

4.3.2 LACK OF AWARENESS FOR THE USE OF ADVANCED TECHNOLOGIES 33

4.4 OPPORTUNITIES 34

4.4.1 ENTERING DEVELOPING ECONOMIES 34

4.4.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 34


5 MARKET FACTOR ANALYSIS 35

5.1 PORTER’S FIVE FORCES MODEL 35

5.1.1 BARGAINING POWER OF SUPPLIERS 35

5.1.2 BARGAINING POWER OF BUYERS 36

5.1.3 THREAT OF NEW ENTRANTS 36

5.1.4 THREAT OF SUBSTITUTES 36

5.1.5 INTENSITY OF RIVALRY 36

5.2 VALUE CHAIN ANALYSIS 37

5.2.1 R&D AND DESIGNING 38

5.2.2 MANUFACTURING 38

5.2.3 DISTRIBUTION 38

5.2.4 MARKETING & SALES 38

5.2.5 POST-SALES MONITORING 38


5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 35

5.1.1 BARGAINING POWER OF SUPPLIERS 35

5.1.2 BARGAINING POWER OF BUYERS 36

5.1.3 THREAT OF NEW ENTRANTS 36

5.1.4 THREAT OF SUBSTITUTES 36

5.1.5 INTENSITY OF RIVALRY 36

5.2 VALUE CHAIN ANALYSIS 37

5.2.1 R&D AND DESIGNING 38

5.2.2 MANUFACTURING 38

5.2.3 DISTRIBUTION 38

5.2.4 MARKETING & SALES 38

5.2.5 POST-SALES MONITORING 38


6 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA
6.1 OVERVIEW 39

6.2 NASO-LABIAL FOLDS 40

6.3 LIPS 41

6.4 MARIONETTE FOLDS 41

6.5 TEMPLES 42

6.6 CHIN 43

6.7 UNDER-EYE AREA 43


7 GLOBAL FACIAL FAT TRANSFER MARKET, TREATMENT
7.1 OVERVIEW 45

7.2 DERMAL FILLERS 46

7.3 FAT INJECTION 48


8 GLOBAL FACIAL FAT TRANSFER MARKET, END USER
8.1 OVERVIEW 49

8.2 HOSPITALS 50

8.3 COSMETIC SURGERY CLINICS 51

8.4 OTHERS 51


9 GLOBAL FACIAL FAT TRANSFER MARKET, BY REGION
9.1 OVERVIEW 52

9.2 AMERICAS 53

9.2.1 NORTH AMERICA 56

9.2.2 LATIN AMERICA 63

9.3 EUROPE 65

9.3.1 WESTERN EUROPE 68

9.4 EASTERN EUROPE 83

9.5 ASIA-PACIFIC 85

9.5.1 JAPAN 88

9.5.2 CHINA 90

9.5.3 INDIA 92

9.5.4 SOUTH KOREA 94

9.5.5 AUSTRALIA 96

9.5.6 REST OF ASIA-PACIFIC 98

9.6 MIDDLE EAST & AFRICA 100

9.6.1 MIDDLE EAST 103

9.6.2 AFRICA 105


10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW 107

10.2 COMPANY SHARE ANALYSIS 107

10.3 COMPETITIVE BENCHMARKING 108

10.4 LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN FACIAL FAT TRANSFER MARKET 109

10.5 KEY DEVELOPMENT ANALYSIS 109

10.5.1 PRODUCT LAUNCH 110

10.5.2 APPROVAL 110

10.5.3 MERGER & ACQUISITION 111

10.5.4 EXPANSION 112

10.5.5 PARTNERSHIPS AND AGREEMENTS 113


11 COMPANY PROFILE
11.1 ALLERGAN 114

11.1.1 COMPANY OVERVIEW 114

11.1.2 FINANCIAL OVERVIEW 115

11.1.3 PRODUCTS/SERVICES OFFERED 115

11.1.4 KEY DEVELOPMENTS 116

11.1.5 SWOT ANALYSIS 117

11.1.6 KEY STRATEGIES 117

11.2 DR. KORMAN 118

11.2.1 COMPANY OVERVIEW 118

11.2.2 FINANCIAL OVERVIEW 118

11.2.3 PRODUCTS/SERVICES OFFERED 118

11.2.4 KEY DEVELOPMENTS 118

11.2.5 SWOT ANALYSIS 119

11.2.6 KEY STRATEGIES 119

11.3 GALDERMA LABORATORIES, L.P. 120

11.3.1 COMPANY OVERVIEW 120

11.3.2 FINANCIAL OVERVIEW 120

11.3.3 PRODUCTS/SERVICES OFFERED 121

11.3.4 KEY DEVELOPMENTS 121

11.3.5 SWOT ANALYSIS 122

11.3.6 KEY STRATEGIES 122

11.4 INTEGRA LIFESCIENCES CORPORATION 123

11.4.1 COMPANY OVERVIEW 123

11.4.2 FINANCIAL OVERVIEW 123

11.4.3 PRODUCTS/SERVICES OFFERED 124

11.4.4 KEY DEVELOPMENTS 124

11.4.5 SWOT ANALYSIS 125

11.4.6 KEY STRATEGIES 125

11.5 MERZ PHARMA 126

11.5.1 COMPANY OVERVIEW 126

11.5.2 FINANCIAL OVERVIEW 126

11.5.3 PRODUCTS/SERVICES OFFERED 127

11.5.4 KEY DEVELOPMENTS 127

11.5.5 SWOT ANALYSIS 128

11.5.6 KEY STRATEGIES 128

11.6 SCIVISION BIOTECH INC. 129

11.6.1 COMPANY OVERVIEW 129

11.6.2 FINANCIAL OVERVIEW 129

11.6.3 PRODUCTS/SERVICES OFFERED 129

11.6.4 KEY DEVELOPMENTS 129

11.6.5 SWOT ANALYSIS 130

11.6.6 KEY STRATEGIES 130

11.7 SINCLAIR PHARMA 131

11.7.1 COMPANY OVERVIEW 131

11.7.2 FINANCIAL OVERVIEW 131

11.7.3 PRODUCTS/SERVICES OFFERED 132

11.7.4 KEY DEVELOPMENTS 132

11.7.5 SWOT ANALYSIS 133

11.7.6 KEY STRATEGIES 133

11.8 SUNEVA MEDICAL 134

11.8.1 COMPANY OVERVIEW 134

11.8.2 FINANCIAL OVERVIEW 134

11.8.3 PRODUCTS/SERVICES OFFERED 134

11.8.4 KEY DEVELOPMENTS 134

11.8.5 SWOT ANALYSIS 135

11.8.6 KEY STRATEGIES 135

11.9 BAUSCH HEALTH COMPANIES INC. 136

11.9.1 COMPANY OVERVIEW 136

11.9.2 FINANCIAL OVERVIEW 136

11.9.3 PRODUCTS/SERVICES OFFERED 137

11.9.4 KEY DEVELOPMENTS 137

11.9.5 SWOT ANALYSIS 138

11.9.6 KEY STRATEGIES 138

11.10 TEOXANE LABORATORIES 139

11.10.1 COMPANY OVERVIEW 139

11.10.2 FINANCIAL OVERVIEW 139

11.10.3 PRODUCTS/SERVICES OFFERED 139

11.10.4 KEY DEVELOPMENTS 139

11.10.5 SWOT ANALYSIS 140

11.10.6 KEY STRATEGIES 140

11.11 IPSEN PHARMA 141

11.11.1 COMPANY OVERVIEW 141

11.11.2 FINANCIAL OVERVIEW 141

11.11.3 PRODUCTS/SERVICES OFFERED 142

11.11.4 KEY DEVELOPMENTS 142

11.11.5 SWOT ANALYSIS 143

11.11.6 KEY STRATEGIES 143

12 APPENDIX
12.1 REFERENCES 144

12.2 RELATED REPORTS 144












 



List of Figures


FIGURE 1 MARKET SYNOPSIS 16

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS (2018) 17

FIGURE 3 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY TARGET AREA 18

FIGURE 4 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY TREATMENT 19

FIGURE 5 GLOBAL FACIAL FAT TRANSFER MARKET ANALYSIS, BY END USER 20

FIGURE 6 GLOBAL FACIAL FAT TRANSFER MARKET: STRUCTURE 21

FIGURE 7 BOTTOM-UP AND TOP-DOWN APPROACHES 28

FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL FACIAL FAT TRANSFER MARKET 31

FIGURE 9 DRIVER IMPACT ANALYSIS 32

FIGURE 10 RESTRAINT IMPACT ANALYSIS 33

FIGURE 11 PORTER’S FIVE FORCES ANALYSIS: GLOBAL FACIAL FAT TRANSFER MARKET 35

FIGURE 12 VALUE CHAIN ANALYSIS OF THE GLOBAL FACIAL FAT TRANSFER MARKET 37

FIGURE 13 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY TARGET AREA, 2018 (%) 39

FIGURE 14 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2018 AND 2025 (USD MILLION) 39

FIGURE 15 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY TREATMENT, 2018 (%) 45

FIGURE 16 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT, 2018 AND 2025 (USD MILLION) 45

FIGURE 17 GLOBAL FACIAL FAT TRANSFER MARKET SHARE, BY END USER, 2018 (%) 49

FIGURE 18 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER, 2018 AND 2025 (USD MILLION) 49

FIGURE 19 GLOBAL: FACIAL FAT TRANSFER MARKET, BY REGION 2016 & 2025 (USD MILLION) 52

FIGURE 20 GLOBAL: FACIAL FAT TRANSFER MARKET SHARE, BY REGION 2018 (%) 52

FIGURE 21 AMERICAS: FACIAL FAT TRANSFER MARKET SHARE, BY REGION 2018 (%) 53

FIGURE 22 NORTH AMERICA: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY 2018 (%) 56

FIGURE 23 EUROPE: PERFUSION RADIOLOGY MARKET SHARE, BY REGION 2018 (%) 65

FIGURE 24 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY 2018 (%) 68

FIGURE 25 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET SHARE, BY COUNTRY2018 (%) 85

FIGURE 26 MIDDLE EAST & AFRICA: PERFUSION RADIOLOGY MARKET SHARE, BY REGION, 2018 (%) 100

FIGURE 27 BENCHMARKING OF MAJOR COMPETITORS 108

FIGURE 28 GLOBAL FACIAL FAT TRANSFER MARKET, COMPETITIVE LANDSCAPE 109

FIGURE 29 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 30 ALLERGAN: SWOT ANALYSIS 117

FIGURE 31 DR. KORMAN: SWOT ANALYSIS 119

FIGURE 32 GALDERMA: FINANCIAL OVERVIEW SNAPSHOT 120

FIGURE 33 GALDERMA: SWOT ANALYSIS 122

FIGURE 34 INTEGRA: FINANCIAL OVERVIEW SNAPSHOT 123

FIGURE 35 INTEGRA: SWOT ANALYSIS 125

FIGURE 36 MERZ PHARMA: FINANCIAL OVERVIEW SNAPSHOT 126

FIGURE 37 MERZ PHARMA: SWOT ANALYSIS 128

FIGURE 38 SCIVISION BIOTECH INC.: SWOT ANALYSIS 130

FIGURE 39 SINCLAIR PHARMA: FINANCIAL OVERVIEW SNAPSHOT 131

FIGURE 40 SINCLAIR PHARMA: SWOT ANALYSIS 133

FIGURE 41 SUNEVA MEDICAL: SWOT ANALYSIS 135

FIGURE 42 BAUSCH: FINANCIAL OVERVIEW SNAPSHOT 136

FIGURE 43 BAUSCH: SWOT ANALYSIS 138

FIGURE 44 TEOXANE: SWOT ANALYSIS 140

FIGURE 45 IPSEN PHARMA: FINANCIAL OVERVIEW SNAPSHOT 141

FIGURE 46 IPSEN PHARMA: SWOT ANALYSIS 143

 

List of Tables


TABLE 1 LIST OF ASSUMPTIONS 22

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 25

TABLE 3 GLOBAL FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 40

TABLE 4 GLOBAL FACIAL FAT TRANSFER MARKET FOR NASO-LABIAL FOLDS, BY REGION, 2016–2025 (USD MILLION) 40

TABLE 5 GLOBAL FACIAL FAT TRANSFER MARKET FOR LIPS, BY REGION, 2016–2025 (USD MILLION) 41

TABLE 6 GLOBAL FACIAL FAT TRANSFER MARKET FOR MARIONETTE FOLDS, BY REGION, 2016–2025 (USD MILLION) 42

TABLE 7 GLOBAL FACIAL FAT TRANSFER MARKET FOR TEMPLES, BY REGION, 2016–2025 (USD MILLION) 42

TABLE 8 GLOBAL FACIAL FAT TRANSFER MARKET FOR CHIN, BY REGION, 2016–2025 (USD MILLION) 43

TABLE 9 GLOBAL FACIAL FAT TRANSFER MARKET FOR UNDER-EYE AREA, BY REGION, 2016–2025 (USD MILLION) 43

TABLE 10 GLOBAL FACIAL FAT TRANSFER MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 46

TABLE 11 GLOBAL FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY REGION, 2016–2025 (USD MILLION) 47

TABLE 12 GLOBAL FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 47

TABLE 13 GLOBAL FACIAL FAT TRANSFER MARKET FOR FAT INJECTION, BY REGION, 2016–2025 (USD MILLION) 48

TABLE 14 GLOBAL FACIAL FAT TRANSFER MARKET, BY END USER, 2016–2025 (USD MILLION) 50

TABLE 15 GLOBAL FACIAL FAT TRANSFER MARKET FOR HOSPITALS, BY REGION, 2016–2025 (USD MILLION) 50

TABLE 16 GLOBAL FACIAL FAT TRANSFER MARKET FOR COSMETIC SURGERY CLINICS, BY REGION, 2016–2025 (USD MILLION) 51

TABLE 17 AMERICAS: FACIAL FAT TRANSFER MARKET, BY REGION, 2016–2025 (USD MILLION) 53

TABLE 18 AMERICAS: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 54

TABLE 19 AMERICAS: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 54

TABLE 20 AMERICAS: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 55

TABLE 21 AMERICAS: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 55

TABLE 22 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 56

TABLE 23 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 57

TABLE 24 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 57

TABLE 25 NORTH AMERICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 58

TABLE 26 NORTH AMERICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 58

TABLE 27 US: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 59

TABLE 28 US: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 59

TABLE 29 US: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 60

TABLE 30 US: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 60

TABLE 31 CANADA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 61

TABLE 32 CANADA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 61

TABLE 33 CANADA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 62

TABLE 34 CANADA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 62

TABLE 35 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 63

TABLE 36 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 63

TABLE 37 LATIN AMERICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 64

TABLE 38 LATIN AMERICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 64

TABLE 39 EUROPE: FACIAL FAT TRANSFER MARKET, BY REGION, 2016–2025 (USD MILLION) 65

TABLE 40 EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 66

TABLE 41 EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 66

TABLE 42 EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 67

TABLE 43 EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 67

TABLE 44 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 68

TABLE 45 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 69

TABLE 46 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 69

TABLE 47 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 70

TABLE 48 WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 70

TABLE 49 ITALY: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 71

TABLE 50 ITALY: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 71

TABLE 51 ITALY: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 72

TABLE 52 ITALY: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 72

TABLE 53 FRANCE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 73

TABLE 54 FRANCE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 73

TABLE 55 FRANCE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 74

TABLE 56 FRANCE: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 74

TABLE 57 GERMANY: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 75

TABLE 58 GERMANY: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 75

TABLE 59 GERMANY: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 76

TABLE 60 GERMANY: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 76

TABLE 61 UK: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 77

TABLE 62 UK: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 77

TABLE 63 UK: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 78

TABLE 64 UK: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 78

TABLE 65 SPAIN: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 79

TABLE 66 SPAIN: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 79

TABLE 67 SPAIN: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 80

TABLE 68 SPAIN: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 80

TABLE 69 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 81

TABLE 70 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 81

TABLE 71 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 82

TABLE 72 REST OF WESTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 82

TABLE 73 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 83

TABLE 74 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 83

TABLE 75 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 84

TABLE 76 EASTERN EUROPE: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 84

TABLE 77 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 85

TABLE 78 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 86

TABLE 79 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 86

TABLE 80 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 87

TABLE 81 ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 87

TABLE 82 JAPAN: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 88

TABLE 83 JAPAN: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 88

TABLE 84 JAPAN: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 89

TABLE 85 JAPAN: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 89

TABLE 86 CHINA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 90

TABLE 87 CHINA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 90

TABLE 88 CHINA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 91

TABLE 89 CHINA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 91

TABLE 90 INDIA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 92

TABLE 91 INDIA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 92

TABLE 92 INDIA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 93

TABLE 93 INDIA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 93

TABLE 94 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 94

TABLE 95 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 94

TABLE 96 SOUTH KOREA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 95

TABLE 97 SOUTH KOREA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 95

TABLE 98 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 96

TABLE 99 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 96

TABLE 100 AUSTRALIA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 97

TABLE 101 AUSTRALIA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 97

TABLE 102 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 98

TABLE 103 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 98

TABLE 104 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 99

TABLE 105 REST OF ASIA-PACIFIC: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 99

TABLE 106 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY REGION, 2016–2025 (USD MILLION) 100

TABLE 107 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 101

TABLE 108 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 101

TABLE 109 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 102

TABLE 110 MIDDLE EAST & AFRICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 102

TABLE 111 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 103

TABLE 112 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 103

TABLE 113 MIDDLE EAST: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 104

TABLE 114 MIDDLE EAST: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 104

TABLE 115 AFRICA: FACIAL FAT TRANSFER MARKET, BY TARGET AREA, 2016–2025 (USD MILLION) 105

TABLE 116 AFRICA: FACIAL FAT TRANSFER MARKET, BY TREATMENT 2016–2025 (USD MILLION) 105

TABLE 117 AFRICA: FACIAL FAT TRANSFER MARKET FOR DERMAL FILLERS, BY TYPE, 2016–2025 (USD MILLION) 106

TABLE 118 AFRICA: FACIAL FAT TRANSFER MARKET, BY END USER 2016–2025 (USD MILLION) 106

TABLE 119 GLOBAL FACIAL FAT TRANSFER MARKET: COMPANY SHARE ANALYSIS, 2018 (%) 107

TABLE 120 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE FACIAL FAT TRANSFER MARKET 109

TABLE 121 PRODUCT LAUNCH 110

TABLE 122 APPROVAL 110

TABLE 123 MERGER & ACQUISITION 111

TABLE 124 EXPANSION 112

TABLE 125 PARTNERSHIPS AND AGREEMENTS 113

TABLE 126 ALLERGAN: PRODUCTS/SERVICES OFFERED 115

TABLE 127 ALLERGAN: KEY DEVELOPMENTS 116

TABLE 128 DR. KORMAN: PRODUCTS/SERVICES OFFERED 118

TABLE 129 GALDERMA: PRODUCTS/SERVICES OFFERED 121

TABLE 130 GALDERMA: KEY DEVELOPMENTS 121

TABLE 131 INTEGRA: PRODUCTS/SERVICES OFFERED 124

TABLE 132 INTEGRA: KEY DEVELOPMENTS 124

TABLE 133 MERZ PHARMA: PRODUCTS/SERVICES OFFERED 127

TABLE 134 MERZ PHARMA: KEY DEVELOPMENTS 127

TABLE 135 SCIVISION BIOTECH INC.: PRODUCTS/SERVICES OFFERED 129

TABLE 136 SINCLAIR PHARMA: PRODUCTS/SERVICES OFFERED 132

TABLE 137 SINCLAIR PHARMA: KEY DEVELOPMENTS 132

TABLE 138 SUNEVA MEDICAL: PRODUCTS/SERVICES OFFERED 134

TABLE 139 SUNEVA MEDICAL: KEY DEVELOPMENTS 134

TABLE 140 BAUSCH: PRODUCTS/SERVICES OFFERED 137

TABLE 141 TEOXANE: PRODUCTS/SERVICES OFFERED 139

TABLE 142 IPSEN PHARMA: PRODUCTS/SERVICES OFFERED 142

TABLE 143 IPSEN PHARMA: KEY DEVELOPMENTS 142